Guo Y, Ohki S, Kawano Y, Kong W, Ohno Y, Honda H
Front Immunol. 2024; 15:1467774.
PMID: 39372408
PMC: 11449725.
DOI: 10.3389/fimmu.2024.1467774.
Takami M, Motohashi S
Front Immunol. 2024; 15:1457771.
PMID: 39224603
PMC: 11366658.
DOI: 10.3389/fimmu.2024.1457771.
Boonchalermvichian C, Yan H, Gupta B, Rubin A, Baker J, Negrin R
Front Transplant. 2024; 3:1353803.
PMID: 38993780
PMC: 11235242.
DOI: 10.3389/frtra.2024.1353803.
Kamii Y, Hayashizaki K, Kanno T, Chiba A, Ikegami T, Saito M
Proc Natl Acad Sci U S A. 2024; 121(9):e2313964121.
PMID: 38394242
PMC: 10907256.
DOI: 10.1073/pnas.2313964121.
Nishio K, Pasquet L, Camara K, DiSapio J, Hsu K, Kato S
J Clin Invest. 2023; 134(4).
PMID: 38127463
PMC: 10866642.
DOI: 10.1172/JCI165281.
SFRP4IGFBP5 NKT cells induced neural-like cell differentiation to contribute to adenomyosis pain.
Chen Y, Zhu J, Chen L, Shen Y, Zhang J, Wang Q
Front Immunol. 2022; 13:945504.
PMID: 36532077
PMC: 9750790.
DOI: 10.3389/fimmu.2022.945504.
Antigen-presenting T cells provide critical B7 co-stimulation for thymic iNKT cell development via CD28-dependent trogocytosis.
Watanabe M, Celli S, Alkhaleel F, Hodes R
Cell Rep. 2022; 41(9):111731.
PMID: 36450247
PMC: 9805342.
DOI: 10.1016/j.celrep.2022.111731.
The tumor innate immune microenvironment in prostate cancer: an overview of soluble factors and cellular effectors.
Palano M, Gallazzi M, Cucchiara M, Deho F, Capogrosso P, Bruno A
Explor Target Antitumor Ther. 2022; 3(5):694-718.
PMID: 36338516
PMC: 9630328.
DOI: 10.37349/etat.2022.00108.
Preface: Unconventional T Cells in Health and Disease.
Van Kaer L
Crit Rev Immunol. 2022; 41(4):v-ix.
PMID: 36047319
PMC: 11007254.
DOI: 10.1615/CritRevImmunol.2021041608.
Off-the-shelf third-party HSC-engineered iNKT cells for ameliorating GvHD while preserving GvL effect in the treatment of blood cancers.
Li Y, Zeng S, Dunn Z, Zhou Y, Li Z, Yu J
iScience. 2022; 25(9):104859.
PMID: 36034226
PMC: 9399487.
DOI: 10.1016/j.isci.2022.104859.
Host-Related Factors as Targetable Drivers of Immunotherapy Response in Non-Small Cell Lung Cancer Patients.
Baci D, Cekani E, Imperatori A, Ribatti D, Mortara L
Front Immunol. 2022; 13:914890.
PMID: 35874749
PMC: 9298844.
DOI: 10.3389/fimmu.2022.914890.
Innate and Innate-like Effector Lymphocytes in Health and Disease.
Van Kaer L, Postoak J, Song W, Wu L
J Immunol. 2022; 209(2):199-207.
PMID: 35821102
PMC: 9285656.
DOI: 10.4049/jimmunol.2200074.
Gadd45 Proteins in Immunity 2.0.
Schmitz I
Adv Exp Med Biol. 2022; 1360:69-86.
PMID: 35505163
DOI: 10.1007/978-3-030-94804-7_5.
Use of a Murine Immunization and Challenge Model to Evaluate Single and Combination Vaccine Adjuvants Consisting of Alum and NKT Cell-Activating Ligands.
Lang G, Norman K, Amadou Amani S, Shadid T, Ballard J, Lang M
Front Immunol. 2022; 12:818734.
PMID: 35095921
PMC: 8794951.
DOI: 10.3389/fimmu.2021.818734.
Transcriptome and Function of Novel Immunosuppressive Autoreactive Invariant Natural Killer T Cells That Are Absent in Progressive Multiple Sclerosis.
Carrion B, Liu Y, Hadi M, Lundstrom J, Romme Christensen J, Ammitzboll C
Neurol Neuroimmunol Neuroinflamm. 2021; 8(6).
PMID: 34385365
PMC: 8362604.
DOI: 10.1212/NXI.0000000000001065.
Targeting Natural Killer T Cells in Solid Malignancies.
Ingram Z, Madan S, Merchant J, Carter Z, Gordon Z, Carey G
Cells. 2021; 10(6).
PMID: 34072042
PMC: 8227159.
DOI: 10.3390/cells10061329.
Lipid homeostasis and mevalonate pathway in COVID-19: Basic concepts and potential therapeutic targets.
Proto M, Fiore D, Piscopo C, Pagano C, Galgani M, Bruzzaniti S
Prog Lipid Res. 2021; 82:101099.
PMID: 33915202
PMC: 8074527.
DOI: 10.1016/j.plipres.2021.101099.
Innate Immune Determinants of Graft-Versus-Host Disease and Bidirectional Immune Tolerance in Allogeneic Transplantation.
Hamers A, Joshi S, Pillai A
OBM Transplant. 2021; 3(1).
PMID: 33511333
PMC: 7839993.
DOI: 10.21926/obm.transplant.1901044.
The Adjuvant of α-Galactosylceramide Presented by Gold Nanoparticles Enhances Antitumor Immune Responses of MUC1 Antigen-Based Tumor Vaccines.
Liu Y, Wang Z, Yu F, Li M, Zhu H, Wang K
Int J Nanomedicine. 2021; 16:403-420.
PMID: 33469292
PMC: 7813472.
DOI: 10.2147/IJN.S273883.
essential oil composition and it's immunostimulatory potential against colon cancer cells.
Chandan G, Kumar C, Verma M, Satti N, Saini A, Saini R
3 Biotech. 2020; 10(10):451.
PMID: 33062579
PMC: 7519027.
DOI: 10.1007/s13205-020-02438-4.